Clal Biotechnology Industries Ltd. Stock TEL AVIV STOCK EXCHANGE
Equities
CBI
IL0011042806
Investment Holding Companies
Sales 2022 | 370K 98.67K 134K | Sales 2023 | 104K 27.73K 37.8K | Capitalization | 62.27M 16.6M 22.63M |
---|---|---|---|---|---|
Net income 2022 | -61M -16.27M -22.17M | Net income 2023 | -31M -8.27M -11.27M | EV / Sales 2022 | 331 x |
Net Debt 2022 | 23.85M 6.36M 8.67M | Net Debt 2023 | 22.4M 5.97M 8.14M | EV / Sales 2023 | 814 x |
P/E ratio 2022 |
-1.6
x | P/E ratio 2023 |
-2.01
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 34.65% |
Managers | Title | Age | Since |
---|---|---|---|
Assaf Segal
CEO | Chief Executive Officer | 51 | 15-06-30 |
Liat Nissan
DFI | Director of Finance/CFO | 46 | - |
Arnon Aharon
CTO | Chief Tech/Sci/R&D Officer | 55 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 67 | 03-05-08 | |
Yuval Yanai
BRD | Director/Board Member | 71 | 15-11-17 |
Gad Keren
BRD | Director/Board Member | 73 | 20-02-16 |
1st Jan change | Capi. | |
---|---|---|
+17.49% | 75.59B | |
+56.21% | 16.95B | |
+4.00% | 15.78B | |
+8.18% | 13.87B | |
-0.40% | 12.3B | |
+9.67% | 12.04B | |
+6.40% | 10.88B | |
+34.86% | 10.17B | |
-1.50% | 9.7B |